Approvals/TGA/PRIMOVIST disodium gadoxetate 181.43 mg/mL (0.25M) 5mL injection vial

Approved

STANDARD

PRIMOVIST disodium gadoxetate 181.43 mg/mL (0.25M) 5mL injection vial

Bayer Australia Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 5ee1b484883fd2f1
Product Name: PRIMOVIST disodium gadoxetate 181.43 mg/mL (0.25M) 5mL injection vial
Artg Id: 102088
Artg Name: PRIMOVIST disodium gadoxetate 181.43 mg/mL (0.25M) 5mL injection vial
Sponsor: Bayer Australia Ltd
Company Detail Path: /organization/bayer-australia-ltd
Artg Date: 2004-07-01
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/18ee57f0cc3a54ff034bcdce0db4fbe5.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/7b32a2a6b8138613fb5f58724848d18a.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

5ee1b484883fd2f1

Type

Standard